|
|
Article: RCT Hits Licensing Milestone for Essential Protein Expression Tool.
- Article from:
- Business Wire
- Article date:
- May 26, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2
TUCSON, Ariz.--(BUSINESS WIRE)--May 26, 2004
Research Corporation Technologies has 100 biotechnology and pharmaceutical companies licensed to use a versatile DNA sequence that enables a high level of protein expression in mammalian cells.
RCT's Gene eXpression Technologies (GXT) licensing program has licensed the bovine growth hormone polyadenylation (bgh-polyA) signal sequence to companies in the United States, Canada, Japan, Europe and Australia.
The bgh-polyA signal is a specialized termination sequence useful for producing pharmaceutical proteins and peptides in mammalian ...